Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by newfrontierMJon Feb 19, 2021 7:44am
175 Views
Post# 32607233

State Marijuana Regulators Outline Policy Priorities...

State Marijuana Regulators Outline Policy Priorities...State Marijuana Regulators Outline Policy Priorities As Congress Pursues Legalization

https://www.cann-ra.org/news-events/cannra-issues-letter-to-congress-highlighting-regulatory-issues-which-impact-state-and-federal-priorities

Dear Madam Speaker, Mr. Leader, Mr. Majority Leader, and Mr. Minority Leader:

The Cannabis Regulators Association (CANNRA) is a national organization that facilitates exchanges between policy makers and cannabis regulators from across the country.

CANNRA provides officials with unbiased information and recommendations regarding the impact and implementation of cannabis policies.

Our members are the primary regulatory agencies and officials charged with oversight of adult-use cannabis (also referred to as “recreational cannabis”) and/or medical cannabis

-->in the states of Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Iowa, Louisiana, Maine, Massachusetts, Maryland, Michigan, Minnesota, Montana, Nevada, New Jersey, New York, North Dakota, Oregon, Rhode Island, South Dakota, Utah, Washington, and Washington D.C.

CANNRA is not a cannabis advocacy group and takes no formal position for or against cannabis legalization.

--> Our mission is to provide policy makers and regulatory agencies with the resources to make informed decisions when considering approaches to cannabis regulation.

The purpose of this letter is to introduce our association as a resource, so that interested members of Congress may benefit from the regulatory and implementation experiences of our members and the states they represent, and to provide a regulatory perspective on federal cannabis legislation.

States across the country continue to experiment with new and changing cannabis policy.

Each of the
---> thirtysix states and four territories that have
--->legalized some form of cannabis,

whether they permit the use of cannabis by patients to treat qualifying medical conditions, use by adults age twenty-one and older, or both,

--> has its own unique regulatory framework.

Licensed activities, tax mechanisms and rates, market structure, the role of local governments, marketing and advertising, approved qualifying medical conditions, and many more regulatory issues vary greatly between jurisdictions. 

<< Previous
Bullboard Posts
Next >>